• Accelerate insights generation on impact of new clinical data, market drivers, barriers, and untapped opportunities, with future sensitivity analysis capabilities by leveraging an Agentic AI powered Disease Area Expert
• GenAI is leveraged to uncover instant insights from two years of market research into developing a comprehensive patient journey. This serves as the foundation for the digital DAE with plans for ongoing enhancements to incorporate various structured and unstructured, internal, and external data such as publications, market access reports, competitive intelligence analysis, and other claims and EMR/HER data.
• The first phase is complete and actively used by the brand team to unlock hidden growth opportunities to drive the brand planning process; Feedback from early users has been inspiring and is guiding future enhancements.

Ajay Chandwani, Head, Market Research and Advanced Analytics, Takeda

Inder Singh, Head of Commercial Analytics and Insights, US Business Unit, Takeda

• Identify key metrics to evaluate actual reach impact against target reach goals, ensuring internal objectives align with external results
• Root your strategy in qualitative metrics that work for you to ensure comparable success that can be translated into customer insights
• Ensure data-driven decision-making is at the heart of future strategy to get ahead of customer needs

• Install a true understanding of customer behaviors and needs by combining data sources to build one succinct customer profile
• Make the ‘right content at the right time’ possible by advancing data analytics capabilities and optimizing LLM models
• Bridge internal data silos to advance agile team performance and unify customer perceptions

Mayank Misra, VP Commercial Strategy, Analytics and Operations, Soleno Therapeutics

Venera Jordan, Global Capability Partner, Omnichannel and Digital, Global Commercial IT, AstraZeneca

Gaurav Jaggi, Director, Strategic Insights & Analytics, Bayer

Moderator: Amy Campion, Senior Vice President of Business Development and Strategy, Timely by DrFirst

• Understand external forces reshaping the healthcare ecosystem—from regulatory shifts to digital disruption—and how they impact engagement models
• Uncover why rare conditions remain underserved and explore how pharma can step in where current systems fall short
• Drive truly patient-centric innovation by integrating advanced digital solutions with cross-functional talent and emerging skillsets

Johanna Rossell, SVP, General Manager Rare Disease, Sumitomo Pharma America
Karin Pihel, Senior Director, Regulatory Affairs, Sumitomo Pharma America

• Discuss how to create a CRM that combines digital, field and medical data into a unified profile, allowing for personalized interactions at scale
• Explain how a future-forward CRM can simplify interactions across stakeholders, allowing field teams and marketers to be more efficient and productive
• Learn how companies are empowering frontline teams with AI to improve decision-making, minimize manual work, and enhance the quality and timing of customer interactions

Elizabeth Otterman, Principal, PwC US
Jacquie Newland, Director, PwC US

• Distinguish between real compliance constraints and internal myths by exploring how to use AI and regulatory intelligence tools
• Assess internal risk aversion by building a shared language between medical and commercial functions
• Implement agile governance models to drive innovation and customer-centricity while maintaining regulatory integrity

Moderator: Supreet Deshpande, Co-Founder & CEO, SynthioLabs

Siddharth Jain, Head (Senior Director), Global Medical Unit for Growth & Launch Brands in Rare Diseases, Takeda

Tyler Redelico, Director, Medical Omnichannel & Content Strategy, AstraZeneca
Chris Chu, Senior Director of Enterprise GenAI Content, Genentech

• Foster a change-ready culture by shaping mindsets and defining clear development pathways
• Meet today’s customer expectations head-on by enabling field force to thrive with skills in data literacy, empathy, and digital fluency
• Review a case study on how a sales rep grew into strategic commercial leader and has led responsibility on cross-functional collaboration

Justin Holko, SVP, Global Oncology & Hematology Commercial Business Unit, Regeneron

• AI solutions for long-term viability
• How we built an AI super agent that delivers practical value
• AI adaptation to evolution
• Survival of the fittest - is "Agentic AI" just clever marketing?

Prasant Vijayakumar, Chief Strategy Officer, Viseven

• Develop KPIs beyond clicks by measuring brand perception and patient access to medicine
• Mitigate strategies dictated by vanity numbers by identifying key indicators based on engagement quality and patient outcomes
• Showcase the contribution of both medical and commercial teams by aligning patient impact and value-based metrics with key business goals

Divyesh Khetia, VP, Head of Medical Channel Excellence, Pfizer
Yalcin Baltali, Director, Resource Allocation, Enterprise Strategy, TAs Lead, Novartis
Jennifer Hooks, Head of Sales and Accounts, US Hematology, Takeda
Moderator: Arindam Mukherjee, Director Data Strategy & Management, Ipsen

• Demonstrate how early AI adoption is already improving patient engagement, accelerating access, and creating operational efficiencies across patient services.
• Envision a future where intelligent systems continuously adapt to patient needs, creating more connected and predictive patient support ecosystems.
• Harness the power of AI to move beyond transactions, enabling dynamic, data-driven experiences that evolve with every patient interaction.
• Redefine patient services by shaping a model that is anticipatory, equitable, and seamlessly embedded across the entire health journey.

Jennifer Hanley, VP and Senior Partner, Service Line Leader Public Market, IBM
Inder Deep Singh, Patient Services Lead, IBM
Terrel Marks, Life Sciences Transformation Leader, IBM

• Reflect on the complex and variable determinants of patient medication adherence behavior from initiation through maintenance and discontinuation
• Learn about behavioral science-driven approaches that focus on outcomes and their determinants, paired with agentic artificial intelligence techniques that enable personalization and context-driven adaptation
• Adopt personalized, person-centered methods to promote adherence that account for individual motivations and barriers to action

Amy Bucher, Chief Behavioral Officer, Lirio

• Harness enterprise-wide audience intelligence to inform content strategies that resonate deeply with HCPs, patients, and payers—ensuring alignment with brand objectives and market needs
• Establish a unified content performance framework that enables continuous measurement, optimization, and orchestration of omnichannel communications—driving a more agile and effective product lifecycle strategy
• Operationalize AI-driven personalization at scale to deliver contextually relevant, compliant content across touchpoints—enhancing engagement, accelerating decision-making, and maximizing ROI across the healthcare ecosystem

Zahir Uddin, Head of Information Technology, SK Life Science

Ridhi Sharma, Global Marketing Director (Neurology), Sanofi

Moderator: Keith Sedlak, Chief Commercial Officer, Health Monitor

Michelle Melka, Senior Director, ROCTAVIAN BU Marketing Lead, BioMarin

• Explore how BMS is using AI and data to transform content strategy—from modular frameworks to dynamic personalization at scale
• Understand how content, insights, and omnichannel capabilities are converging to deliver more meaningful HCP engagement
• Learn what it takes to operationalize this transformation—from pilot projects to enterprise-wide enablement—and what it means for the future of pharma marketing

Anvita Karara, Head & VP, Worldwide Commercialization Excellence, Bristol Myers Squibb

Sumanth Srinivas, VP, Worldwide Commercialization Excellence - AI & Omnichannel, Bristol Myers Squibb

Brian Mangene, VP, Commercialization Model Excellence, Bristol Myers Squibb

Robert Allen, Executive Director, Omnichannel Strategy US Oncology, Bristol Myers Squibb